Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma

NCT00085462 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

NIH

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: filgrastim
BIOLOGICAL: gp100-fowlpox vaccine
BIOLOGICAL: therapeutic autologous lymphocytes
BIOLOGICAL: therapeutic tumor infiltrating lymphocytes
DRUG: cyclophosphamide
DRUG: fludarabine phosphate

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]